Ohcanbohtosat - Huide Zhu

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Bearbmagovva

    Cost-effectiveness analysis of sugemalimab vs. chemotherapy as first-line treatment of metastatic nonsquamous non-small cell lung cancer Dahkki Zhiwei Zheng, Huide Zhu, Ling Fang, Hongfu Cai

    Almmustuhtton 2022
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Bearbmagovva

    Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy vs. Chemotherapy Alone as First-Line Treatment in Patients With Esophageal Squamous Cell Carcinoma and PD-L1 CPS of 1... Dahkki Zhiwei Zheng, Jingrong Lin, Huide Zhu, Hongfu Cai

    Almmustuhtton 2022
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Bearbmagovva

    Cost-effectiveness analysis of lenvatinib plus pembrolizumab compared with chemotherapy for patients with previously treated mismatch repair proficient advanced endometrial cancer... Dahkki Zhiwei Zheng, Liu Yang, Siqi Xu, Huide Zhu, Hongfu Cai

    Almmustuhtton 2022
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: